| INTRODUCTION
Successful reproduction is a defining process for species survival during which parental genes are faithfully replicated in the offspring and the need for high-fidelity duplication of those genomes in the progeny is balanced against the adaptive advantages of genetic diversity. At a molecular level, reproduction is also, in many ways, an ongoing battle between the need for faithful reproduction of parental genomes and the replication of an extraordinary number of transposable elements (TE or transposons) that are embedded within animal genomes (Saito & Siomi, 2010) . These TEs are often comprised of remnant sequences from ancestral viruses that have become incorporated into the germline DNA. Unconstrained TE mobilization within animal genomes may have general deleterious effects on the host cell, yet more limited expression may be necessary for cellular and organismal adaptation in some contexts by generating diversity through mutation and alternate patterns of gene expression. This balance between suppression and permission of TE expression may be particularly relevant in domestic species where many elements of adaptation and "natural" selection have been subverted to enhance traits desirable for production or physical appearance (Leroy, Opsomer, Van Soom, Goovaerts, & Bols, 2008) at the cost of decreasing reproductive fitness. The mechanisms behind this decrease may well include changes in the normal molecular pathways that control gene (and transposon) expression in gametes and early embryos. Improved understanding of the complex molecular events surrounding TE expression and its control in gamete and embryo biology is fundamentally interesting from a biological perspective and may inform the development of strategies to slow the fertility decline in domestic mammals.
| REPROGRAMMING AND EPIGENETICS
Gametes and embryos are obviously critical participants in reproduction. One of the earliest and most important processes to occur during both gametogenesis and embryogenesis is a series of events known as reprogramming, which involves the removal of epigenetic marks that control the pattern of gene expression, identity and function of any given cell, thereby allowing differentiation into other cell types (Hajkova et al., 2002; Hill, Amouroux, & Hajkova, 2014; Morgan, Santos, Green, Dean, & Reik, 2005) . This differentiation capacity is referred to as "potency," with a "totipotent" zygote able to generate the many different cell types required in the organism and its extraembryonic tissues. Cellular potency typically decreases with successive divisions, producing increasingly specialized cell types throughout development (Piferrer, 2013) . The primary epigenetic factors that determine potency are DNA methylation, histone modifications and the non-coding RNA (ncRNA) complement within the cell (Piferrer, 2013 ).
As mentioned above, there are two periods in the eukaryotic life cycle where potency is restored through reprogramming (Figure 1 ). The first is immediately upon fusion of the gametes to form the zygote, and the second occurs during the formation of the primordial germ cells (PGCs) which give rise to the gametes (Saitou, Kagiwada, & Kurimoto, 2012) . In both cases, the genome is stripped of essentially all heterochromatic marks that restrict developmental capacity.
Reprogramming of both the maternal and paternal genomes in the early embryo is required for normal development. Once the sperm enters the oocyte, maternally deposited factors (proteins) begin stripping the densely packed genetic material of repressive epigenetic marks through active mechanisms that occur before the first round of DNA replication (Oswald et al., 2000) . After active demethylation of the DNA in paternal pronuclei, both parental genomes undergo replication-dependent, passive demethylation, due in part to the absence of the maintenance methyltransferase DNMT1 from the nucleus of the early embryo (Uysal, Akkoyunlu, & Ozturk, 2015) . The result is global methylation loss over several successive replication and cleavage events, with the exception of some imprinted genes, retrotransposons and centromeric heterochromatin Lane et al., 2003; Morgan et al., 2005; Oswald et al., 2000) .
A second wave of reprogramming occurs in the PGCs of the developing embryo and is required to re-establish foetal-specific imprinting and to regain the epigenetic potential required for fertilization and development in the next generation. It has been postulated that the few loci that are not demethylated may be the carriers of transgenerational epigenetic memory (Lane et al., 2003) . PGC reprogramming begins in mouse foetal gonads approximately embryonic day 8.5 (E8.5), while parental imprints remain until E11.5 (Hajkova et al., 2002) . Following the completion of reprogramming in PGCs at E13.5, the genome exhibits the lowest level of DNA methylation present during development (Hill et al., 2014; Saitou et al., 2012) .
F I G U R E 1 Reprogramming during the mammalian life cycle. (a) During the establishment of PGCs in the foetal gonad, there is genomewide demethylation until sex differentiation when the 5mC levels are the lowest seen during the life cycle. In both sexes, programming steadily increases during gamete development. (b) Upon fusion of the mature, differentiated gametes, the paternal genome is actively demethylated while both genomes undergo passive demethylation after fusion and during subsequent replication events. Modified and adapted from Saitou et al. (2012) (Adelson, Raison, & Edgar, 2009 ) and 40.0% in the pig (Groenen et al., 2013) . Demethylation events during reprogramming increase retrotransposon expression, which is often followed by re-integration at different sites in the genome and genetic damage to the host (Maksakova et al., 2006) . Widespread re-integration of retrotransposons during reprogramming in model species leads to genetic instability and cell death, resulting in gamete or embryo loss and infertility.
| TRANSPOSABLE ELEMENTS
Since their discovery, TEs have become one the most fascinating and mysterious branches of genome biology. Sequencing of the human genome led to the striking discovery that almost 50% of human DNA is composed of TEs and their derivatives (Lander et al., 2001) . The vast majority of TEs are dormant and fragmented, incapable of transposition. However, a few copies remain complete and active; ~10% of spontaneous genome mutations in rodents are believed to be the result of TE mobilization (Maksakova et al., 2006) . These findings raise important questions such as: Why has evolution tolerated the replication of seemingly "unnecessary" DNA, how has the cell adapted to the presence of potentially active viral fragments, and what costs and benefits do these TEs provide to the host? TE biology is briefly highlighted here, and covered in depth elsewhere (Chuong, Elde, & Feschotte, 2017) .
| TYPES AND MOBILIZATION OF TES
Transposition is the process by which a TE is expressed, replicated and re-integrated to a different physical location in the genome (McClintock, 1950) . Several types of TEs exist and they are functionally divided into two distinct classes based on their mechanism of transposition. Class I elements are referred to as retrotransposons and mobilize through a RNA intermediate that is transcribed in a manner similar to a gene, with the potential to re-integrate into the genome through reverse transcriptase activity (Wicker et al., 2007) . Class II elements, called DNA transposons, replicate by multiple mechanisms (Wicker et al., 2007) . Common class I elements include long terminal repeat (LTR)/endogenous retroviruses (ERV), non-LTR retrotransposons including the long interspersed nuclear elements (LINEs) and the non-autonomous, short interspersed nuclear elements (SINEs). Given their ability to replicate, retrotransposons have a greater genomic abundance, while their class II counterparts comprise only approximately 2% of the bovine genome (Adelson et al., 2009 ). For reviews of TE classifications, see Kapitonov and Jurka (2008) and Wicker et al. (2007) . A schematic representation of LINE and SINE TE expression and transposition is presented in Figure 2 .
While the outcome of transposition is most commonly considered neutral due to re-integration in non-coding regions of the genome, transposition may be associated with negative outcomes such as cancer, genetic diseases and infertility (Belancio, Roy-Engel, & Deininger, 2010; Kazazian et al., 1988; Maksakova et al., 2006; Saito & Siomi, 2010) . Paradoxically, the expression of TEs and their truncated transcripts appears to be required during early embryonic development in specific contexts (Beraldi, Pittoggi, Sciamanna, Mattei, & Spadafora, 2006) , although the mechanisms through which they promote favourable outcomes remains unclear. For example, suppression of L1 ORF through antisense targeting in mouse zygotes leads to a decrease in reverse transcriptase activity after which embryos arrest with high frequency at the two-cell stage (Beraldi et al., 2006) . Also in mice, the ERV MuERV-L is expressed as one of the first transcripts emerging from the quiescent genome, 8 hr after fertilization (Kigami, Minami, Takayama, & Imai, 2003) .
Knockdown of MuERV-L leads to a developmental block at the fourcell stage, demonstrating the requirement for this TE in embryogenesis.
Human embryos also express TEs, including LINEs such as L1, SINEs, including Alu and SVA, and LTRs like HERV-K (Grow et al., 2015; Guo et al., 2014) . Research on embryonic TE expression in domestic animals is limited; however, some studies have investigated expression of bovine TEs. Both in vitro-produced (IVP) and cloned (SCNT) embryos show abundant TE expression (Bui et al., 2009; Li et al., 2014) at various developmental stages, although more work is required to determine their importance in preimplantation development.
In contrast to the apparent requirement for TE expression during embryogenesis, research in gametes and the germline has focused largely on the mechanisms that mediate TE repression. Failure of these repressive pathways to maintain silencing through transcriptional and post-transcriptional mechanisms leads to genomic instability, meiotic arrest and infertility in both sexes (Carmell et al., 2007; Flemr et al., 2013; Kuramochi-Miyagawa et al., 2008) . However, there have been several reports of an abundant LTR family, Mouse Transcript (MT), expressed in neonatal to mature oocytes (Holt, Roman, Aitken, & McLaughlin, 2006; Park et al., 2004) and accounts for 10% of the total transcript numbers (Peaston et al., 2004) . RNAi-mediated suppression of MT expression in GV oocytes leads to failed germinal vesicle breakdown (GVBD), implicating MT in the events of oocyte maturation (Park et al., 2004) . Therefore, it appears that strict regulation is necessary to ensure that sufficient MT is present for GVBD, but also to ensure that levels are not high enough to cause genomic instability.
Based on the studies described above and other similar work, the prevailing view regarding TEs in the genome has begun to shift away from one in which TEs are viewed as "deleterious" or "junk DNA" that must be suppressed to avoid negative phenotypes, to one in which they are considered key "evolutionary drivers" and "exaptation mediators" (Chuong et al., 2017) that are damaging when inappropriately expressed, but necessary when appropriately constrained. This has important implications for the evolution of biological pathways that control their activity, as complete inhibition of these "parasitic" genomic elements has not been favoured by evolution. This view is consistent with mechanistic studies, suggesting that TEs are differentially regulated under stress. The plant stress-TE connection has been well established, wherein the activity of TEs after tissue damage, introduction of pathogens or heat stress is increased (reviewed in Ref. (Capy, Gasperi, Biémont, & Bazin, 2000; Wessler, 1996) 
| THE PIWI PATHWAY
One of the most important and widely recognized pathways controlling TE expression during reprogramming is the PIWI (P-elementInduced WImpy testes) pathway, named for the phenotype of Drosophila mutants carrying genetic defects in this pathway. Much of the initial mechanistic work has been performed in Drosophila and murine models; however, recent studies (Kowalczykiewicz, Pawlak, Lechniak, & Wrzesinski, 2012; Russell et al., 2016 Russell et al., , 2016 Stalker, Russell, Co, Foster, & LaMarre, 2015) have confirmed that these pathways are also present in domestic animals and appear to play similar roles. Table 1 summarizes the PIWI proteins in different species.
The PIWI pathway is a small RNA-based, transcriptional and posttranscriptional regulatory system that has become prominent in the field of RNA interference over the past decade. PIWI proteins and their associated PIWI-interacting RNAs (piRNAs) were originally described in gametes and subsequently identified as key participants in the control of retrotransposon expression (Aravin et al., 2001; Deng, Lin, & Carolina, 2002; Vagin et al., 2006) . Since the original identification of their roles in gametogenesis, many additional studies have implicated them in oncology, neurology, viral immunity and embryology (Table 1) (Iwasaki, Siomi, & Siomi, 2015; Sun et al., 2017) . The PIWI pathway consists of two central components: PIWI proteins and piRNAs (Aravin et al., 2006; Brennecke et al., 2007; Vagin et al., 2006) . PIWI proteins, present in both invertebrates and vertebrates, are members of the Argonaute protein family. piRNAs bind to PIWI proteins and form piRNA ribonucleoprotein (piRNP) or piRNA-induced silencing complexes (piRISCs) that target and repress complementary TE or mRNA transcripts in a manner functionally analogous in many ways to the more widely studied microRNA pathway.
| PIWI AND PIWI-LIKE PROTEINS
The PIWI gene was first identified while screening mutations that affected the maintenance of germline stem cells (GSCs) in Drosophila (Lin & Spradling, 1997) . Mutations in the PIWI gene lead to a loss in both female and male germline stem cells (GSCs) (Cox et al., 1998) .
Two other Drosophila PIWI proteins, Aubergine (Aub) and Argonaute3 (Ago3), were later identified as structurally similar to PIWI (Harris & Macdonald, 2001; Williams & Rubin, 2002) . PIWI proteins contain four primary domains: N-terminal, PIWI/Argonaute/Zwille (PAZ), MID and the catalytic PIWI domain. These structural features, along with GSC localization and maintenance, led to the identification of homologs across species (Houwing et al., 2007; Juliano et al., 2014; Kawaoka, Minami, Katsuma, Mita, & Shimada, 2008) .
Following discoveries in Drosophila, one mouse PIWI homolog, MIWI (PIWI-like 1, or PIWIL1), was shown to be a cytoplasmic protein required for normal mammalian spermatogenesis (Deng et al., 2002) . The expression of PIWIL1 begins at 14 days post-partum (dpp)
in pachytene spermatocytes and persists to the round spermatid stage (Deng et al., 2002) with similar patterns in the dog (Stalker et al., 2015) and bull (Russell et al., 2016) . PIWIL1 functions to maintain GSCs The mouse has been the primary focus for most mammalian PIWI protein studies. However, the murine genome lacks PIWIL3, which is present in many other mammalian genomes (Gu et al., 2010; Roovers et al., 2015) . Recent studies have suggested that expression of PIWIL3 in cattle may be largely restricted to oocytes and embryos (Roovers et al., 2015) with potentially important roles in oogenesis and embryonic reprogramming. This finding is likely to be particularly relevant to reproduction in domestic animals and humans, as female PIWI knockout mice (PIWIL1, L2) remain fertile, likely due to the presence of a unique isoform of Dicer (Dicer (O)) which generates endo-siRNAs that mediate retrotransposon suppression (Flemr et al., 2013) . As Dicer (O) is not present in species other than the mouse and rat, the role of retrotransposon suppression likely falls to PIWIL3 (Roovers et al., 2015) . Alternatively (or in addition), MARF1, a recently characterized protein, may play important roles in TE suppression in mammals (Su et al., 2012) .
T A B L E 1 PIWI Proteins in different organisms

| EXPRESSION OF PIRNA PRECURSORS FROM CLUSTERS IN THE GENOME
PIWI-interacting RNAs that bind to PIWI proteins originate as noncoding piRNA precursors that are transcribed from piRNA dense loci in the genome known as piRNA clusters (Vourekas et al., 2012) . Some of these clusters (known as pre-pachytene clusters) are enriched for repetitive elements and transposon fragments, which essentially serve as "genetic memory" for past retroviral infections that have been transmitted through the germline (Brennecke et al., 2007) . Similar to the sequence diversity observed in immune-related genes, piRNA clusters acquire TE fragments and mutate frequently in an attempt to maintain suppression of dynamic target TEs (Bergman, Quesneville, Anxolabéhère, & Ashburner, 2006; Both, Taylor, Pollard, & Steele, 1990 ). These piRNA clusters number from hundreds to thousands in animal genomes and generate the majority of piRNAs found in cells (Girard et al., 2006) . However, the factors that control their expression (transcription factors, epigenetic state) are still not fully understood.
Cluster expression occurs in Drosophila nurse cells and in develop-
ing spermatocytes of mice and other animals (Aravin et al., 2006; Brennecke et al., 2007; Girard et al., 2006; Lau, Ohsumi, Borowsky, Kingston, & Blower, 2009; Russell et al., 2016) . They are transcribed from a single transcription start site, either uni-or bidirectionally, by RNA Polymerase II (Pol II). These precursors are initially processed similarly to mRNA, with 5′ capping, polyadenylation and, potentially, alternative splicing (Goriaux, Desset, Renaud, Vaury, & Brasset, 2014; Li et al., 2013) . In mammals, the transcription factor A-MYB is required for the expression of genes encoding piRNA biogenesis proteins such as PIWIL1 and the bidirectional expression of pachytene piRNA clusters (Li et al., 2013) . In contrast, pre-pachytene piRNA clusters appear to be transcribed unidirectionally (for a comprehensive recent review of piRNA biogenesis, see Hirakata & Siomi, 2016) .
| PRECURSOR EXPORT AND PROCESSING
Once transcribed, piRNA precursors must be transported from the nucleus to peri-nuclear structures called the nuage, which has several aliases and functional differences depending on content and the species involved: germ granules, Yb bodies, chromatoid bodies, pi-bodies and piP-bodies (Meikar et al., 2014; Pillai & Chuma, 2012) . The nuage is composed of mRNA processing machinery organized into granular structures in the nuclear periphery (reviewed by Ishizu, Siomi, and Siomi (2012) ). These granular structures are known sites of decay, storage and quality assessment of RNA exported from the nucleus (Kulkarni, Ozgur, & Stoecklin, 2010; Meikar et al., 2014) . The mechanisms for export to the nuage are active subjects of research and beyond the scope of this review.
After nuclear export, precursors undergo several maturation steps aided by the localization of cofactors to the "processing scaf- to Zuc (Frost et al., 2010; Vourekas et al., 2015) and Minotaure (Vagin et al., 2013) . Loading of piRNA intermediates onto their associated PIWI proteins requires the co-chaperone Shutdown (Shu) and heat-shock protein 90 (HSP90), which are both well conserved and localized to Yb bodies/nuage (Izumi et al., 2013; Olivieri, Senti, Subramanian, Sachidanandam, & Brennecke, 2012) .
Once loaded onto the PIWI protein with which they associate, piRNA intermediates are trimmed at their 3′ ends. The length of the resulting mature piRNA appears to correspond to its specific PIWI partner. In mouse, the peak of mature piRNAs bound to PIWIL1, PIWIL2, and PIWIL4 are 29-30 nt, 26-27 nt, 27-28 nt in length, respectively (Kuramochi-Miyagawa et al., 2008; Vourekas et al., 2012) .
Once mature piRNAs are bound to PIWI proteins, they are methylated at their 3′ termini by Hen1/Pimet which generates a protective 2′-O-methyl modification (Horwich et al., 2007; Saito et al., 2007) .
Mature piRNA-PIWI protein complexes will hereafter be referred to as piRNA-induced silencing complexes, or piRISCs. These events lead to the formation of piRNAs, which are antisense to their targets (usually TEs) and are collectively termed primary piRNA biogenesis (Figure 3 ). The piRISC complex mediates at least two processes: the cleavage of complementary RNA targets such as retrotransposonencoded RNAs through nuclease "slicer" activity in the cytoplasm (reviewed in Hirakata & Siomi, 2016) and epigenetic changes in chromatin confirmation in flies (Sienski, Dönertas, & Brennecke, 2012) or DNA methylation in the mouse (Kuramochi-Miyagawa et al., 2008) .
| THE PING-PONG AMPLIFICATION LOOP
One of the hallmarks of the piRNA pathway in germ cells is an unusual feed-forward piRNA biogenesis mechanism known as the "ping-pong" amplification loop ( Figure 3C ). The amplification loop constitutes secondary piRNA biogenesis. First identified in Drosophila, piRNAs bound to PIWI proteins target TEs in the cytoplasm and cleave the target RNA through slicer (nuclease) activity (Brennecke et al., 2007; Gunawardane et al., 2007) . Instead of being degraded, the cleavage products are loaded onto another PIWI protein (Ago3) as piRNA intermediates (Reviewed in Hirakata & Siomi, 2016) . The formation of a mature piRNA from a target transcript is considered secondary piRNA biogenesis. These 
| PIWI PATHWAY ROLES IN REPRODUCTION
The cleavage of expressed TE transcripts during secondary piRNA biogenesis reflects what is probably the primary and most highly conserved function of the PIWI pathway between taxa: posttranscriptional gene silencing (PTGS) of TEs through the slicer activity of piRISCs. Slicer activity of PIWIL1 is also required for cleavage of both TEs and mRNA targets, recognized through complementarity with bound piRNAs (Reuter et al., 2011; Zhang et al., 2015) (Fig. 3B ).
Several members of the PIWI protein family also appear to participate in transcriptional gene silencing (TGS), primarily through directing DNA methylation and histone modifications (Carmell et al., 2007; Klenov et al., 2014) . Early studies of PIWI depletion demonstrated a loss in repressive epigenetic modifications at TE loci (Klenov et al., 2011) .
More recent investigations reveal that PIWI binding to target loci, likely Products from the amplification loop are loaded onto MIWI2 (PIWIL4) which translocates to the nucleus and directs target locus methylation, in a MAEL-dependent manner (Feltzin et al., 2015; Grivna, Pyhtila, & Lin, 2006; Li et al., 2013; Manakov et al., 2015; Reuter et al., 2011; Soper et al., 2008; Vourekas et al., 2015; Watanabe et al., 2011b; reviewed in Hirakata & Siomi, 2016) through interactions with nascent RNAs, leads to the deposition of repressive H3K9me3 histone marks (Le Thomas et al., 2013; Post, Clark, Sytnikova, Chirn, & Lau, 2014) . Moreover, mutated slicer-inactive PIWI retains its competence to direct TGS by abolishing RNA Pol II occupancy (Klenov et al., 2011; Sienski et al., 2012 ). PIWIL4 appears to have similar roles in transcriptional repression, but directs DNA methylation rather than histone modifications . It is likely that additional mechanisms of TGS in mammals that operate through the PIWI pathway have yet to be uncovered.
Through the pathways described above and others involving DNA and histone methylation, the key roles of the PIWI pathway in gamete and embryo development appear to be the short-term (through posttranscriptional mechanisms) and longer-term (through re-methylation of TE DNA and histone modification) epigenetic suppression of TEs that represent a large portion of most mammalian genomes .
One significant recent development with respect to roles that PIWI proteins and piRNAs may play in reproduction is the growing body of evidence that this pathway participates in the silencing of protein coding mRNAs in addition to retrotransposon targeting (Gebert, Ketting, Zischler, & Rosenkranz, 2015; Gou et al., 2014; Rouget et al., 2010) . This was first reported in Drosophila, where the decay of nanos transcripts is directed by PIWI and specific piRNAs (Rouget et al., 2010) . Subsequent studies have provided strong evidence that the turnover of mRNAs expressed during the pachytene stage of spermatogenesis and is mediated by the piRNA pathway in multiple species (Gebert et al., 2015; Gou et al., 2014; Reuter et al., 2011) . Very recently, we have identified piRNA-like RNAs with sequences that appear to target mRNAs present in bovine testes and oocytes (Russell et al., 2016b) , suggesting that they may participate in mRNA turnover during bovine spermatogenesis and the maternal to zygotic transition during embryo development. Some controversy remains in this area, particularly in the early embryo, and it will be important to functionally validate the role of the PIWI pathway in this context before it can be definitively implicated in these processes in mammals.
| CONCLUSIONS AND FUTURE DIRECTIONS
Epigenetic reprogramming in gametes and embryos is indispensable for successful reproduction but presents unique windows of host vulnerability for the emergence of viral elements that have become integrated into animal genomes. Some evidence suggests that limited expression of retrotransposons may be required for embryo development, although this has not been shown in gametes.
Retrotransposon expression in these periods may facilitate genetic diversity, which implies that natural selection may favour organisms that limit, rather than completely eliminate, the process. Over the past decade, the PIWI clade of argonaute proteins, along with their associated small RNAs, has emerged as key participant in the control of retrotransposon expression during reprogramming. Additional roles in post-transcriptional mRNA turnover as well as cancer, stem cell and neurobiology have recently been described. Many questions remain concerning the nature of this pathway and its roles in infertility and disease states. Specific questions of particular importance relate to the roles of PIWIL3 in the oocyte and early embryo, the importance of mRNA targeting by piRISC to gametogenesis and embryogenesis and the roles that TEs play in the developing embryo and how their expression is coupled to development. Future studies will likely need to focus on the ongoing tension between retrotransposon expression and the pathways that have evolved to limit it, the roles of this balance in animal reproduction and disease and how the balance may be manipulated to alter fertility outcomes.
